Prognosis associated with surgery for non-small cell lung cancer and synchronous brain metastasis

Surgery Today

Volumn 44, Issue 7, 2014, Pages 1321-1327

  Kanou, Takashi ^a   Okami, Jiro ^a   Tokunaga, Toshiteru ^a   Fujiwara, Ayako ^a   Ishida, Daisuke ^a   Kuno, Hidenori ^a   Higashiyama, Masahiko ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Brain metastasis; Lung cancer; Resection; Synchronous

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; BRAIN METASTASIS; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CRANIOTOMY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE; MALE; MIDDLE AGED; OVERALL SURVIVAL; RETROSPECTIVE STUDY; STEREOTACTIC RADIOSURGERY; SURVIVAL RATE; SYNCHRONOUS BRAIN METASTASIS; THORAX SURGERY; TUMOR VOLUME; AGED; BLOOD; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; MORTALITY; NEUROSURGERY; PATHOLOGY; PATIENT SELECTION; PROGNOSIS; SECONDARY;

AGED; BRAIN NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PATIENT SELECTION; PNEUMONECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84903271006     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-014-0895-3     Document Type: Article

References (23)

1. Quint LE, Tummala S, Brisson LJ, Francis IR, Krupnick AS, Kazerooni EA, et al. Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg. 1996;62(1):246-50. (Pubitemid 26239872)
2. Sorensen JB, Hansen HH, Hansen M, Dombernowsky P. Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis. J Clin Oncol. 1988;6(9):1474-80. (Pubitemid 19089037)
3. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys. 1999;43(4):795-803. (Pubitemid 29152652)
4. Rodrigus P, de Brouwer P, Raaymakers E. Brain metastases and non-small cell lung cancer. Prognostic factors and correlation with survival after irradiation. Lung Cancer. 2001;32(2):129-36. (Pubitemid 32372605)
5. Takeshima H, Kuratsu J, Nishi T, Ushio Y. Prognostic factors in patients who survived more than 10 years after undergoing surgery for metastatic brain tumors: report of 5 cases and review of the literature. Surg Neurol. 2002;58(2):118-23 discussion 123.
6. Granone P, Margaritora S, D'Andrilli A, Cesario A, Kawamukai K, Meacci E. Non-small cell lung cancer with single brain metastasis: the role of surgical treatment. Eur J Cardiothorac Surg. 2001;20(2):361-6. (Pubitemid 32706622)
7. Burt M, Wronski M, Arbit E, Galicich JH. Resection of brain metastases from non-small-cell lung carcinoma. Results of therapy. Memorial Sloan-Kettering Cancer Center Thoracic Surgical Staff. J Thorac Cardiovasc Surg. 1992;103(3):399-410 discussion 410-391.
8. Billing PS, Miller DL, Allen MS, Deschamps C, Trastek VF, Pairolero PC. Surgical treatment of primary lung cancer with synchronous brain metastases. J Thorac Cardiovasc Surg. 2001; 122(3):548-53. (Pubitemid 32843957)
9. Bonnette P, Puyo P, Gabriel C, Giudicelli R, Regnard JF, Riquet M, et al. Surgical management of non-small cell lung cancer with synchronous brain metastases. Chest. 2001;119(5):1469-75. (Pubitemid 32686031)
10. Chidel MA, Suh JH, Greskovich JF, Kupelian PA, Barnett GH. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis. Radiat Oncol Investig. 1999;7(5):313-9. (Pubitemid 29522080)
11. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363(9422):1665-72. (Pubitemid 38670323)
12. Endoh H, Yamamoto R, Satoh Y, Kuwano H, Nishizawa N. Risk analysis of pulmonary resection for elderly patients with lung cancer. Surg Today. 2013;43(5):514-20.
13. Okamoto T, Iwata T, Mizobuchi T, Hoshino H, Moriya Y, Yoshida S, et al. Surgical treatment for non-small cell lung cancer with ipsilateral pulmonary metastases. Surg Today. 2013;43(10): 1123-8.
14. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2007;2(8):706-14. (Pubitemid 47357522)
15. Penel N, Brichet A, Prevost B, Duhamel A, Assaker R, Dubois F, et al. Prognostic factors of synchronous brain metastases from lung cancer. Lung Cancer. 2001;33(2-3):143-54. (Pubitemid 32707895)
16. Magilligan DJ Jr, Duvernoy C, Malik G, Lewis JW Jr, Knighton R, Ausman JI. Surgical approach to lung cancer with solitary cerebral metastasis: 25 years' experience. Ann Thorac Surg. 1986;42(4):360-4. (Pubitemid 16033263)
17. Torre M, Barbieri B, Bera E, Locicero S, Pieri Nerli F, Belloni PA. Surgical therapy in lung cancer with single brain metastasis. Eur J Cardiothorac Surg. 1988;2(5):336-9.
18. Rossi NP, Zavala DC, VanGilder JC. A combined surgical approach to non-oat-cell pulmonary carcinoma with single cerebral metastasis. Respiration. 1987;51(3):170-8. (Pubitemid 17067485)
19. Iwasaki A, Shirakusa T, Yoshinaga Y, Enatsu S, Yamamoto M. Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor. Eur J Cardiothorac Surg. 2004;26(3):488-93. (Pubitemid 39091984)
20. Mussi A, Pistolesi M, Lucchi M, Janni A, Chella A, Parenti G, et al. Resection of single brain metastasis in non-small-cell lung cancer: prognostic factors. J Thorac Cardiovasc Surg. 1996; 112(1):146-53. (Pubitemid 26268981)
21. Park SJ, Kim HT, Lee DH, Kim KP, Kim SW, Suh C, et al. Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation. Lung Cancer. 2012;77(3):556-60.
22. Bartolotti M, Franceschi E, Brandes AA. EGF receptor tyrosine kinase inhibitors in the treatment of brain metastases from non-small- cell lung cancer. Expert Rev Anticancer Ther. 2012;12(11): 1429-35.
23. Detterbeck FC, Jones DR, Kernstine KH, Naunheim KS. Lung cancer. Special treatment issues. Chest. 2003;123(1 Suppl):244S-58S.